White Maple Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-12-2024
- Paid Up Capital ₹ 0.30 M
as on 02-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 02-12-2024
- Revenue 44.36%
(FY 2020)
- Profit 8.06%
(FY 2020)
- Ebitda 408.82%
(FY 2020)
- Net Worth 44.59%
(FY 2020)
- Total Assets 40.88%
(FY 2020)
About White Maple Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹3.00 M.
Pabitra Baruah, Premananda Das, and Priteeshree Baruah serve as directors at the Company.
- CIN/LLPIN
U24230AS2016PTC012342
- Company No.
012342
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Dibrugarh, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does White Maple Pharmaceuticals Private Limited offer?
White Maple Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Laxatives, Anti Infective Drugs & Medicines, Antibacterial Drugs, Wood, Plywood, Veneer & Laminates, Hardwood.
Who are the key members and board of directors at White Maple Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Premananda Das  | Director | 12-Feb-2016 | Current |
| Pabitra Baruah | Director | 12-Feb-2016 | Current |
| Priteeshree Baruah | Director | 12-Feb-2016 | Current |
Financial Performance of White Maple Pharmaceuticals.
White Maple Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 44.36% increase. The company also saw a slight improvement in profitability, with a 8.06% increase in profit. The company's net worth Soared by an impressive increase of 44.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of White Maple Pharmaceuticals?
In 2018, White Maple Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2020 | Syndicate Bank | ₹3.00 M | Open |
How Many Employees Work at White Maple Pharmaceuticals?
White Maple Pharmaceuticals has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of White Maple Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White Maple Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.